SCPX
Scorpius Holdings, Inc.
Price Chart
Latest Quote
$0.00
-0.01 (-90.09%)
Current Price
| Previous Close | $0.01 |
| Open | $0.01 |
| Day High | $0.01 |
| Day Low | $0.01 |
| Volume | 60,814 |
Stock Information
| Shares Outstanding | 61.14M |
| Total Debt | $18.12M |
| Cash Equivalents | $601K |
| Revenue | $1.72M |
| Net Income | $-25.18M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $67K |
| EPS (TTM) | $-4.18 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $11.93M |
| Sales | $1.72M |
| Income | $-25.18M |
| Book/sh | $-0.02 |
| Cash/sh | $0.01 |
| Employees | 90 |
Financial Ratios
| Quick Ratio | 0.07 |
| Current Ratio | 0.10 |
Returns & Margins
| ROA | -47.94% |
| ROE | -303.40% |
| Operating Margin | -2056.82% |
Ownership
| Insider Ownership | 0.06% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.00 |
| P/S | 0.04 |
| P/B | -0.05 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 50.00 |
| ATR | 0.0056 |
| Shares Float | 61.12M |
| Short Float | 2.25% |
| Short Ratio | 0.56 |
| Volatility | -5.66 |
Performance History
| Week | -21.43% |
| Month | +0.00% |
| Quarter | -91.06% |
| 6 Months | +10.00% |
| YTD | +450.00% |
| Year | -97.44% |
| 3 Years | -100.00% |
| 5 Years | -100.00% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-15 | $0.00 | 0 |
| 2026-06-12 | $0.00 | 11,079 |
| 2026-06-11 | $0.01 | 114,717 |
| 2026-06-10 | $0.01 | 23,276 |
| 2026-06-09 | $0.00 | 33,438 |
| 2026-06-08 | $0.00 | 5,175 |
| 2026-06-05 | $0.00 | 0 |
| 2026-06-04 | $0.00 | 0 |
| 2026-06-03 | $0.00 | 802 |
| 2026-06-02 | $0.00 | 2,676 |
| 2026-06-01 | $0.00 | 2,421 |
| 2026-05-29 | $0.00 | 3,010 |
| 2026-05-28 | $0.00 | 0 |
| 2026-05-27 | $0.00 | 3,481 |
| 2026-05-26 | $0.00 | 134 |
| 2026-05-22 | $0.00 | 470 |
| 2026-05-21 | $0.00 | 338 |
| 2026-05-20 | $0.00 | 0 |
| 2026-05-19 | $0.00 | 260 |
| 2026-05-18 | $0.00 | 627 |
About Scorpius Holdings, Inc.
Scorpius Holdings, Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company engages in clinical and commercial drug substance manufacturing; and release and stability testing activities. It is also involved in the provision of various process development services, including upstream and downstream development and optimization, and analytical method development solutions, as well as cell line development, testing, and characterization services. The company serves the biotechnology and biopharmaceutical industries. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in San Antonio, Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on SCPX.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $3,196,245 | $2,736,998 | $81,295 | $0 |
| Cost Of Revenue | $3,196,245 | $2,736,998 | $81,295 | $0 |
| Total Revenue | $6,243,022 | $6,994,838 | $370,176 | $0 |
| Operating Revenue | $6,243,022 | $6,994,838 | $370,176 | $0 |
| Expenses | ||||
| Interest Expense | $953,173 | $776,838 | $182,509 | - |
| Total Expenses | $39,094,037 | $49,027,010 | $40,435,336 | $31,170,701 |
| Other Income Expense | $-545,830 | $18,222 | $-2,330,582 | $-5,191,396 |
| Other Non Operating Income Expenses | $292,617 | $-104,822 | $-482,689 | $-123,278 |
| Net Non Operating Interest Income Expense | $-930,943 | $-319,649 | $804,738 | $815,316 |
| Interest Expense Non Operating | $953,173 | $776,838 | $182,509 | - |
| Operating Expense | $35,897,792 | $46,290,012 | $40,354,041 | $31,170,701 |
| General And Administrative Expense | $21,570,874 | $26,170,221 | $20,130,546 | $16,828,229 |
| Other Operating Expenses | - | - | $-402,176 | $-2,112,806 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-32,807,843 | $-40,146,461 | $-40,947,576 | $-35,071,468 |
| Net Interest Income | $-930,943 | $-319,649 | $804,738 | $815,316 |
| Interest Income | $22,230 | $457,189 | $987,247 | $815,316 |
| Normalized Income | $-31,969,396 | $-40,267,845 | $-39,109,277 | $-30,024,162 |
| Net Income From Continuing And Discontinued Operation | $-32,807,843 | $-45,217,168 | $-43,434,706 | $-35,071,468 |
| Total Operating Income As Reported | $-33,600,261 | $-42,032,172 | $-40,222,645 | $-35,419,039 |
| Net Income Common Stockholders | $-32,807,843 | $-45,217,168 | $-43,434,706 | $-35,071,468 |
| Net Income | $-32,807,843 | $-45,217,168 | $-43,434,706 | $-35,071,468 |
| Net Income Including Noncontrolling Interests | $-34,327,788 | $-46,833,186 | $-43,862,197 | $-35,400,807 |
| Net Income Discontinuous Operations | $0 | $-5,070,707 | $-2,487,130 | - |
| Net Income Continuous Operations | $-34,327,788 | $-41,762,479 | $-41,375,067 | $-35,400,807 |
| Pretax Income | $-34,327,788 | $-42,333,599 | $-41,591,004 | $-35,546,781 |
| Special Income Charges | $-1,309,246 | $0 | $-157,485 | $-4,248,338 |
| Interest Income Non Operating | $22,230 | $457,189 | $987,247 | $815,316 |
| Operating Income | $-32,851,015 | $-42,032,172 | $-40,065,160 | $-31,170,701 |
| Gross Profit | $3,046,777 | $4,257,840 | $288,881 | $0 |
| Depreciation Amortization Depletion Income Statement | - | - | $1,030,625 | $0 |
| Depreciation And Amortization In Income Statement | - | - | $1,030,625 | $0 |
| Amortization Of Intangibles Income Statement | - | - | $1,030,625 | $0 |
| Per Share | ||||
| Diluted EPS | $-13.04 | $-347.50 | $-340.00 | $-282.00 |
| Basic EPS | $-13.04 | $-347.50 | $-340.00 | $-282.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $1,660 | $-9,594 | $-20,812 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-25,382,019 | $-34,114,299 | $-36,414,962 | $-25,494,916 |
| Total Unusual Items | $-838,447 | $123,044 | $-1,847,893 | $-5,068,118 |
| Total Unusual Items Excluding Goodwill | $-838,447 | $123,044 | $-1,847,893 | $-5,068,118 |
| Reconciled Depreciation | $7,154,149 | $7,565,506 | $3,145,640 | $607,667 |
| EBITDA (Bullshit earnings) | $-26,220,466 | $-33,991,255 | $-38,262,855 | $-30,563,034 |
| EBIT | $-33,374,615 | $-41,556,761 | $-41,408,495 | $-31,170,701 |
| Diluted Average Shares | $2,515,742 | $130,120 | $128,031 | $124,569 |
| Basic Average Shares | $2,515,742 | $130,120 | $128,031 | $124,569 |
| Diluted NI Availto Com Stockholders | $-32,807,843 | $-45,217,168 | $-43,434,706 | $-35,071,468 |
| Minority Interests | $1,519,945 | $1,616,018 | $427,491 | $329,339 |
| Tax Provision | $0 | $-571,120 | $-215,937 | $-145,974 |
| Other Special Charges | $560,000 | - | - | - |
| Impairment Of Capital Assets | $1,939,246 | $0 | $0 | $1,452,338 |
| Restructuring And Mergern Acquisition | $-1,190,000 | $0 | $-3,342,515 | $430,000 |
| Gain On Sale Of Security | $470,799 | $123,044 | $-1,690,408 | $-819,780 |
| Research And Development | $14,326,918 | $20,119,791 | $20,223,495 | $16,455,278 |
| Selling General And Administration | $21,570,874 | $26,170,221 | $20,130,546 | $16,828,229 |
| Other Gand A | $21,570,874 | $26,170,221 | $20,130,546 | $16,828,229 |
| Write Off | - | $0 | $3,500,000 | $2,366,000 |
| Amortization | - | - | $1,030,625 | $0 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $6,299,620 | $31,396,532 | $73,922,847 | $109,608,314 |
| Total Assets | $39,177,719 | $51,037,627 | $104,396,912 | $120,961,233 |
| Total Non Current Assets | $35,916,764 | $46,276,768 | $54,342,652 | $21,629,863 |
| Other Non Current Assets | $203,135 | $203,135 | $12,438,334 | $12,193,540 |
| Non Current Prepaid Assets | $271,449 | $251,115 | $270,461 | $205,901 |
| Non Current Accounts Receivable | $1,100,000 | $1,720,000 | - | $1,318,359 |
| Current Assets | $3,260,955 | $4,760,859 | $50,054,260 | $99,331,370 |
| Other Current Assets | $228,704 | $316,663 | $1,132,502 | $460,030 |
| Prepaid Assets | $831,913 | $380,182 | $358,621 | $2,426,490 |
| Inventory | $198,688 | $909,158 | $0 | - |
| Receivables | $838,510 | $763,376 | $1,605,978 | $66,049 |
| Other Receivables | $695,041 | $120,184 | $1,524,522 | - |
| Accounts Receivable | $143,469 | $375,192 | $81,456 | $66,049 |
| Cash Cash Equivalents And Short Term Investments | $1,163,140 | $2,391,480 | $39,029,023 | $96,378,801 |
| Cash And Cash Equivalents | $1,027,997 | $184,925 | $3,191,714 | $8,053,879 |
| Assets Held For Sale Current | - | $0 | $7,928,136 | - |
| Goodwill And Other Intangible Assets | - | - | $11,971,334 | $3,500,000 |
| Other Intangible Assets | - | - | $8,669,375 | $3,500,000 |
| Taxes Receivable | - | - | $600,877 | $0 |
| Debt | ||||
| Net Debt | $14,987,403 | - | - | - |
| Total Debt | $28,548,576 | $14,042,043 | $9,298,824 | $1,927,202 |
| Long Term Debt And Capital Lease Obligation | $11,113,146 | $12,613,154 | $8,599,921 | $1,316,285 |
| Current Debt And Capital Lease Obligation | $17,435,430 | $1,428,889 | $698,903 | $610,917 |
| Current Debt | $16,015,400 | - | - | - |
| Other Current Borrowings | $16,015,400 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $37,500,241 | $22,743,292 | $31,960,244 | $8,927,662 |
| Total Non Current Liabilities Net Minority Interest | $13,211,146 | $12,643,154 | $13,922,921 | $4,206,917 |
| Derivative Product Liabilities | $2,098,000 | $0 | $0 | $11,020 |
| Non Current Deferred Liabilities | $0 | $30,000 | $32,500 | $250,937 |
| Current Liabilities | $24,289,095 | $10,100,138 | $18,037,323 | $4,720,745 |
| Current Deferred Liabilities | $1,635,852 | $2,359,441 | $1,585,808 | $0 |
| Payables And Accrued Expenses | $4,919,723 | $5,979,167 | $5,639,142 | $2,883,280 |
| Payables | $3,227,313 | $4,148,747 | $4,253,732 | $1,117,782 |
| Total Tax Payable | $0 | $38,800 | $40,000 | $195,000 |
| Accounts Payable | $3,227,313 | $4,109,947 | $4,213,732 | $922,782 |
| Liabilities Heldfor Sale Non Current | - | $0 | $5,290,500 | - |
| Other Current Liabilities | - | $313,254 | $9,622,279 | $767,370 |
| Other Payable | - | $313,254 | $426,025 | - |
| Other Non Current Liabilities | - | - | $5,290,500 | $2,628,675 |
| Non Current Deferred Taxes Liabilities | - | - | $0 | $215,937 |
| Income Tax Payable | - | - | $1,092,560 | $0 |
| Equity | ||||
| Common Stock Equity | $6,299,620 | $31,396,532 | $73,922,847 | $113,108,314 |
| Total Equity Gross Minority Interest | $1,677,478 | $28,294,335 | $72,436,668 | $112,033,571 |
| Stockholders Equity | $6,299,620 | $31,396,532 | $73,922,847 | $113,108,314 |
| Gains Losses Not Affecting Retained Earnings | $224,110 | $48,877 | $51,924 | $-67,941 |
| Other Equity Adjustments | $224,110 | $48,877 | $51,924 | $-67,941 |
| Retained Earnings | $-287,178,670 | $-254,370,827 | $-209,153,659 | $-165,718,953 |
| Other | ||||
| Ordinary Shares Number | $5,083,268 | $131,097 | $128,307 | $128,249 |
| Share Issued | $5,083,268 | $131,097 | $128,307 | $128,249 |
| Tangible Book Value | $6,299,620 | $31,396,532 | $73,922,847 | $109,608,314 |
| Invested Capital | $22,315,020 | $31,396,532 | $73,922,847 | $113,108,314 |
| Working Capital | $-21,028,140 | $-5,339,279 | $32,016,937 | $94,610,625 |
| Capital Lease Obligations | $12,533,176 | $14,042,043 | $9,298,824 | $1,927,202 |
| Total Capitalization | $6,299,620 | $31,396,532 | $73,922,847 | $113,108,314 |
| Minority Interest | $-4,622,142 | $-3,102,197 | $-1,486,179 | $-1,074,743 |
| Additional Paid In Capital | $293,253,163 | $285,718,456 | $283,019,456 | $278,890,153 |
| Capital Stock | $1,017 | $26 | $5,126 | $5,055 |
| Common Stock | $1,017 | $26 | $5,126 | $5,055 |
| Non Current Deferred Revenue | $0 | $30,000 | $32,500 | $35,000 |
| Long Term Capital Lease Obligation | $11,113,146 | $12,613,154 | $8,599,921 | $1,316,285 |
| Current Deferred Revenue | $1,635,852 | $2,359,441 | $1,585,808 | $0 |
| Current Capital Lease Obligation | $1,420,030 | $1,428,889 | $698,903 | $610,917 |
| Pensionand Other Post Retirement Benefit Plans Current | $298,090 | $332,641 | $491,191 | $459,178 |
| Current Accrued Expenses | $1,692,410 | $1,830,420 | $1,385,410 | $1,765,498 |
| Duefrom Related Parties Non Current | $1,100,000 | $1,720,000 | $0 | - |
| Net PPE | $34,342,180 | $44,102,518 | $41,633,857 | $4,412,063 |
| Accumulated Depreciation | $-3,000,816 | $-7,580,993 | $-2,953,617 | $-1,503,736 |
| Gross PPE | $37,342,996 | $51,683,511 | $44,587,474 | $5,915,799 |
| Leases | $1,335,655 | $2,827,289 | $2,486,329 | $22,563 |
| Construction In Progress | $57,521 | $9,414 | $2,053,335 | $309,620 |
| Other Properties | $35,064,695 | $47,718,715 | $39,255,394 | $5,432,439 |
| Machinery Furniture Equipment | $885,125 | $1,128,093 | $792,416 | $151,177 |
| Properties | $0 | $0 | $0 | $0 |
| Duefrom Related Parties Current | $0 | $268,000 | $0 | - |
| Other Short Term Investments | $135,143 | $2,206,555 | $35,837,309 | $88,324,922 |
| Goodwill | - | - | $3,301,959 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-26,881,796 | $-33,518,152 | $-25,818,362 | $-40,033,619 |
| Operating Activities | ||||
| Operating Cash Flow | $-26,006,641 | $-31,532,595 | $-5,700,364 | $-38,128,906 |
| Cash Flow From Continuing Operating Activities | $-26,006,641 | $-31,532,595 | $-5,700,364 | $-38,128,906 |
| Operating Gains Losses | $654,065 | $-1,467,451 | $-11,020 | $-22,758 |
| Investing Activities | ||||
| Capital Expenditure | $-875,155 | $-1,985,557 | $-20,117,998 | $-1,904,713 |
| Investing Cash Flow | $1,214,170 | $32,236,595 | $10,991,604 | $9,770,265 |
| Cash Flow From Continuing Investing Activities | $1,214,170 | $32,236,595 | $10,991,604 | $9,770,265 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $25,339,129 | $65,624 | $59,692 | $26,304,282 |
| Financing Cash Flow | $25,636,356 | $-8,952,074 | $-4,906,941 | $25,490,349 |
| Cash Flow From Continuing Financing Activities | $25,636,356 | $-8,952,074 | $-4,906,941 | $25,490,349 |
| Net Other Financing Charges | $-2,224,045 | $-6,434,115 | $-4,735,000 | $-658,184 |
| Net Common Stock Issuance | $25,339,129 | $65,624 | $59,692 | $26,304,282 |
| Common Stock Issuance | $25,339,129 | $65,624 | $59,692 | $26,304,282 |
| Other | ||||
| Repayment Of Debt | $-898,774 | $-2,583,583 | $-231,633 | $-183,010 |
| Issuance Of Debt | $3,228,750 | $0 | - | $0 |
| End Cash Position | $1,027,997 | $184,925 | $8,434,554 | $8,053,879 |
| Beginning Cash Position | $184,925 | $8,434,554 | $8,053,879 | $10,931,890 |
| Effect Of Exchange Rate Changes | $-813 | $-1,555 | $-3,624 | $-9,719 |
| Changes In Cash | $843,885 | $-8,248,074 | $384,299 | $-2,868,292 |
| Proceeds From Stock Option Exercised | $191,296 | $0 | $0 | $27,261 |
| Net Issuance Payments Of Debt | $2,329,976 | $-2,583,583 | $-231,633 | $-183,010 |
| Net Short Term Debt Issuance | $2,253,750 | $0 | - | - |
| Short Term Debt Issuance | $2,253,750 | $0 | - | - |
| Net Long Term Debt Issuance | $76,226 | $-2,583,583 | $-231,633 | $-183,010 |
| Long Term Debt Payments | $-898,774 | $-2,583,583 | $-231,633 | $-183,010 |
| Long Term Debt Issuance | $975,000 | $0 | - | $0 |
| Net Investment Purchase And Sale | $2,072,411 | $34,001,350 | $50,786,171 | $11,674,978 |
| Sale Of Investment | $3,008,050 | $34,484,847 | $53,243,519 | $78,635,257 |
| Purchase Of Investment | $-935,639 | $-483,497 | $-2,457,348 | $-66,960,279 |
| Net PPE Purchase And Sale | $-858,241 | $-1,764,755 | $-19,729,895 | $-1,904,713 |
| Sale Of PPE | $16,914 | $220,802 | $388,103 | $0 |
| Purchase Of PPE | $-875,155 | $-1,985,557 | $-20,117,998 | $-1,904,713 |
| Change In Working Capital | $-1,688,308 | $1,783,234 | $32,364,402 | $-14,678,644 |
| Change In Other Working Capital | $-923,347 | $771,133 | $1,583,308 | $-952,191 |
| Change In Other Current Assets | $0 | $-645,931 | $75,291 | $-12,193,540 |
| Change In Payables And Accrued Expense | $-924,448 | $-2,038,404 | $173,168 | $802,086 |
| Change In Accrued Expense | $-42,021 | $-1,921,496 | $-3,126,158 | $929,023 |
| Change In Payable | $-882,427 | $-116,908 | $3,299,326 | $-126,937 |
| Change In Account Payable | $-882,427 | $-116,908 | $3,299,326 | $-126,937 |
| Change In Prepaid Assets | $-783,894 | $2,773,893 | $-5,904 | $-1,144,037 |
| Change In Inventory | $710,470 | $-909,158 | $5,844,000 | $0 |
| Change In Receivables | $232,911 | $1,831,701 | $24,748,069 | $-1,208,248 |
| Changes In Account Receivables | $232,911 | $-293,698 | $-15,967 | $110,111 |
| Other Non Cash Items | $-770,724 | $-665,835 | $-3,335,432 | $535,779 |
| Stock Based Compensation | $1,033,718 | $2,628,276 | $4,085,737 | $6,168,981 |
| Unrealized Gain Loss On Investment Securities | $-999 | $-123,019 | $1,701,443 | $842,538 |
| Asset Impairment Charge | $1,939,246 | $6,151,000 | $3,500,000 | $3,818,338 |
| Deferred Tax | $0 | $-571,120 | $-3,288,937 | - |
| Deferred Income Tax | $0 | $-571,120 | $-3,288,937 | - |
| Depreciation Amortization Depletion | $7,154,149 | $7,565,506 | $3,145,640 | $607,667 |
| Depreciation And Amortization | $7,154,149 | $7,565,506 | $3,145,640 | $607,667 |
| Amortization Cash Flow | $0 | $1,091,250 | $1,030,625 | $0 |
| Amortization Of Intangibles | $0 | $1,091,250 | $1,030,625 | $0 |
| Depreciation | $7,154,149 | $6,474,256 | $2,115,015 | $607,667 |
| Gain Loss On Investment Securities | $-469,800 | - | $-11,020 | $-22,758 |
| Gain Loss On Sale Of PPE | $563,865 | $0 | - | - |
| Gain Loss On Sale Of Business | $0 | $-1,467,451 | $0 | - |
| Net Income From Continuing Operations | $-34,327,788 | $-46,833,186 | $-43,862,197 | $-35,400,807 |
| Net Business Purchase And Sale | - | $0 | $-20,064,672 | $0 |
| Sale Of Business | - | $0 | $2,719,899 | $0 |
| Purchase Of Business | - | $0 | $-22,784,571 | $0 |
| Change In Other Current Liabilities | - | $0 | $-53,530 | $17,286 |
Fetched: 2026-02-02